Sweet's syndrome

L12_SWEET_SDR

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L98.2 Cause of death: ICD-10 — L98.2 2 out of 7 registries used, show all original rules.	62
4. Check minimum number of events None	62
5. Include endpoints None	62
6. Filter based on genotype QC (FinnGen only)	52

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF7

NAME	L12_SWEET_SDR
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L982
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L982
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sweet's syndrome based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Febrile neutrophilic dermatosis [Sweet]

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	272	141	130
Only index persons	252	130	122
Unadjusted period prevalence (%)
Whole population	0.00	0.00	0.00
Only index persons	0.00	0.00	0.00
Median age at first event (years)
Whole population	58.60	57.94	59.42
Only index persons	57.46	55.77	59.27

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	52	34	18
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	61.03	60.89	61.29

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
54: Matched controls
540

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L98.2

ICD-10 Finland

Febrile neutrophilic dermatosis [Sweet]

+∞

77.3

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

13.8

20.7

L30.9

ICD-10 Finland

Dermatitis, unspecified

9.7

16.3

R50.9

ICD-10 Finland

Fever, unspecified

10.0

16.2

A49.9

ICD-10 Finland

Bacterial infection, unspecified

10.8

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

6.8

9.4

H02AB06

ATC

prednisolone; systemic

6.0

8.0

198

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

14.9

6.9

L04AX01

ATC

azathioprine; systemic

26.4

6.9

GD1AA

NOMESCO Finland

Thorax X-ray examination

4.8

6.3

213

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768443) Skin Pathology biopsy report

12.50

12.08

1.7

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

7.75

11.40

6.4

1.4

—

(42870588) Differential panel, method unspecified - Blood

164

7.23

10.28

19.1

5.4

—

(3021440) Promyelocytes/Leukocytes in Blood

6.97

10.01

11.8

7.0

0.09

0.08

0.04

(3017181) Myelocytes/Leukocytes in Blood

6.63

9.52

11.8

6.8

0.82

0.60

0.28

(3023368) Bacteria identified in Blood by Culture

140

5.26

8.23

11.9

4.4

—

(3002179) Metamyelocytes/Leukocytes in Blood

6.09

8.16

12.3

6.9

0.50

0.08

—

(3025159) Blasts/Leukocytes in Blood

5.93

7.93

12.6

8.3

0.44

0.00

—

(3007164) IgA [Mass/volume] in Serum or Plasma

110

4.89

7.77

2.3

1.4

2.97

2.80

g/l

0.09

(3007853) Bacteria identified in Skin by Aerobe culture

5.09

7.33

2.9

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4.60

6.88

2.5

1.9

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4.80

6.65

2.0

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4.89

6.60

3.5

4.7

—

(3042936) Bacteria identified in Isolate by Culture

4.54

6.52

3.6

2.4

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

21.13

6.51

1.1

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

4.46

6.50

1.7

1.4

274.29

594.00

titre

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

6.65

6.20

1.5

1.3

—

(3026782) Osmolality of Urine

4.09

5.97

2.8

3.3

516.82

515.88

mosm/kgh2o

0.01

(40760888) Immunoglobulin light chains.free panel - Serum

13.17

5.52

7.0

8.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

8.89

5.46

1.9

—

(3000093) Morphology [Interpretation] in Blood Narrative

+∞

5.28

1.4

0.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

11.69

5.25

1.4

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4.16

5.22

1.8

1.7

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

4.04

5.19

8.4

4.8

1.13

1.01

mmol/l

0.51

(3037756) Immunofixation for Serum or Plasma

10.51

5.00

5.2

1.2

—

(3022145) Colonoscopy Study observation

3.85

4.72

1.4

1.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

7.90

4.72

1.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

11.46

4.69

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

6.61

4.58

1.5

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

10.18

4.44

1.1

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.18

4.44

1.1

1.4

—

(3004616) Nuclear Ab [Presence] in Serum

13.13

4.41

1.1

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

8.05

4.36

1.4

1.0

—

(3000850) Epithelial cells [#/volume] in Urine

114

3.22

4.20

3.2

3.1

7.17

4.55

e6/l

0.88

108

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

11.24

4.14

1.4

1.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

116

3.15

4.05

13.9

6.3

—

(3000494) Fungus identified in Specimen by Culture

3.54

4.05

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

8.30

4.02

1.4

2.0

—

(3035715) Granulocytes [#/volume] in Blood

8.30

4.02

4.1

1.4

4.76

5.72

e9/l

—

(40761536) Microorganisms panel - Urine sediment

3.85

3.99

4.7

4.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

13.24

3.86

1.5

1.2

—

(3035933) Granulocytes/Leukocytes in Blood

6.51

3.84

5.4

1.5

60.56

61.59

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

7.60

3.82

1.5

1.6

14.10

10.70

mg/l

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

4.67

3.78

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

6.50

3.48

1.1

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

7.84

3.48

1.1

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

7.84

3.48

1.4

2.1

—

(4035726) Immunohistochemistry procedure

4.11

3.37

1.8

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

9.44

3.35

1.5

1.9

—

(3029937) Albumin [Presence] in Urine by Test strip

151

2.77

3.32

5.0

4.2

0.00

estimate

-0.00

(3026008) Bacteria identified in Urine by Culture

152

2.75

3.27

3.0

2.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

242

2.92

3.24

13.2

6.6

1.20

1.22

mmol/l

1.00

212

(36304419) Bacteria [Presence] in Urine

145

2.72

3.20

3.6

3.2

—

estimate

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

5.67

3.19

2.0

1.3

1.06

1.17

g/l

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

5.67

3.19

1.3

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

3.22

3.08

1.4

1.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

6.00

2.97

1.4

1.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2.89

2.95

1.8

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

7.33

2.95

1.5

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

5.57

2.83

1.4

2.3

24.97

25.16

mmol/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

9.01

2.80

1.0

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

9.01

2.80

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

9.01

2.80

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

9.01

2.80

1.4

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

9.01

2.80

1.6

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

9.01

2.80

1.4

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

9.01

2.80

1.0

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

9.01

2.80

1.4

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

9.01

2.80

1.4

1.5

—

(40768804) Tissue Pathology biopsy report

196

2.55

2.80

2.3

1.9

—

(21494890) Protein electrophoresis panel - 24 hour Urine

7.72

2.60

5.6

1.0

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

4.86

2.57

1.1

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2.60

2.53

1.3

1.4

—

(3031040) Bacteria [#/volume] in Urine by Automated count

324

2.93

2.50

6.5

4.6

—

105.67

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4.08

2.47

2.1

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

6.74

2.42

2.0

1.9

227.40

199.63

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

6.74

2.42

3.6

1.9

31.00

31.75

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2.48

2.38

1.7

1.3

28.91

4.39

u/ml

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

162

2.33

2.37

3.6

2.2

143.56

161.66

u/l

0.12

154

(3018418) pH of Serum or Plasma

162

2.33

2.37

8.0

4.3

7.42

7.40

1.22

111

(3041096) Erythrocytes [Presence] in Urine by Automated

154

2.33

2.34

4.1

3.2

0.00

estimate

-0.00

(3010421) pH of Blood

5.04

2.34

2.0

4.9

7.42

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3.39

2.27

1.9

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

270

2.38

2.18

4.7

3.9

0.00

estimate

-0.00

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

5.38

2.12

2.0

77.80

91.40

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

5.38

2.12

1.4

1.9

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

5.38

2.12

1.4

1.9

—

(3049717) Cytology report of Urine Cyto stain

5.38

2.12

3.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

2.39

2.09

1.7

—

(3009261) Glucose [Presence] in Urine by Test strip

274

2.31

2.04

4.7

4.0

0.00

estimate

-0.00

(3035350) Ketones [Presence] in Urine by Test strip

274

2.31

2.04

4.7

3.9

0.00

estimate

-0.00

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

198

2.16

2.00

4.5

3.8

0.00

estimate

-0.00

(1616796) Gas panel - Central venous blood

4.88

1.98

2.6

2.8

—

(40767503) Oxygen content in Capillary blood by calculation

4.88

1.98

1.8

3.4

16.52

15.68

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

4.88

1.98

1.6

1.5

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

4.47

1.86

1.2

1.0

—

(3015736) pH of Urine

214

2.05

1.77

3.3

3.5

6.03

6.21

0.45

114

(3034770) Mitochondria Ab [Titer] in Serum

3.82

1.65

1.0

1.2

—

(21494755) Public health laboratory ask at order entry panel

0.00

1.61

0.0

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

3.56

1.56

2.0

1.5

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

2.43

1.45

1.3

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

126

1.93

1.41

1.5

1.3

2.15

1.76

u/ml

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2.80

1.41

1.0

1.6

—

(40758558) Short blood count panel - Blood

145

1.87

1.35

21.5

6.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.79

1.24

2.8

3.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.79

1.24

3.2

1.9

—

(3019060) Gas panel - Arterial blood

2.44

1.15

6.6

3.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

226

1.74

1.14

2.8

2.1

88.83

98.73

pmol/l

0.64

103

(3022313) Gas panel - Capillary blood

2.52

1.11

6.8

4.7

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

109

1.82

1.11

2.0

1.3

12.16

35.23

iu/ml

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

127

1.77

1.08

11.4

2.4

—

(3044640) Blood type and Crossmatch panel - Blood

172

1.71

1.07

10.8

2.3

—

(40768797) Stomach Pathology biopsy report

1.88

1.03

1.5

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

202

1.67

1.02

6.4

4.3

46.08

27.01

ng/l

0.77

140

(3003396) Base excess in Arterial blood by calculation

2.00

1.00

15.3

6.9

1.74

0.73

mmol/l

—

(3016502) Oxygen saturation in Arterial blood

1.96

0.95

15.3

6.6

95.09

96.29

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.82

0.95

3.0

3.2

3.29

3.86

e6/l

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2.12

0.90

19.3

8.2

24.80

24.38

mmol/l

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.12

0.90

18.8

8.1

23.90

24.92

mmol/l

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1.89

0.86

15.3

6.4

11.24

12.83

kpa

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1.89

0.86

15.3

6.4

5.20

5.11

kpa

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.81

0.0

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.80

0.0

1.9

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.76

0.79

1.0

1.5

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

482

0.60

0.74

4.5

5.4

4.73

4.64

mmol/l

0.16

453

(3025941) Bacteria identified in Stool by Culture

2.01

0.72

1.4

1.2

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1.59

0.63

2.9

0.06

0.96

e6/l

—

(3027008) Opiates [Presence] in Urine

0.00

0.62

0.0

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

0.61

0.0

1.0

—

(1002224) Polysomnography panel

0.00

0.61

0.0

1.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.80

0.60

1.2

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

477

0.66

0.56

4.4

5.3

1.40

1.52

mmol/l

0.91

445

(3002256) Pathology report gross observation

1.60

0.54

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

485

0.65

0.46

5.2

6.2

2.65

2.68

mmol/l

0.09

451

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

249

1.36

0.45

9.3

2.7

—

estimate

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.57

0.42

12.0

4.2

4.44

4.27

pmol/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.42

0.0

1.4

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

165

1.34

0.39

4.0

3.4

1972.66

1592.92

ng/l

0.19

138

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.45

0.38

19.5

5.4

103.20

103.89

mmol/l

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.52

0.37

1.7

1.5

—

(3013512) EKG study

177

1.31

0.35

3.8

3.6

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1.31

0.31

20.6

6.4

103.71

121.24

g/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.24

0.22

1.6

1.7

—

(3019230) Fractional oxyhemoglobin in Venous blood

0.00

0.21

0.0

2.8

—

53.08

—

(3019225) pH of Specimen

1.31

0.21

7.5

3.5

7.39

7.26

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.4

—

7.40

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

3.1

—

20.46

—

(3000991) Gas panel - Venous blood

1.25

0.21

19.7

7.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.15

0.16

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

294

1.13

0.11

2.8

3.1

—

(36660697) Celiac disease serology panel - Serum

1.15

0.10

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

154

0.88

0.09

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

121

0.99

0.00

4.0

—

(1761868) Lipid panel - Serum or Plasma

205

1.04

0.00

2.3

3.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.4

—

(3012441) Differential panel - Pleural fluid

0.00

0.0

2.4

—

(3045716) Anion gap in Serum or Plasma by calculation

0.00

0.0

1.9

—

10.25

—

(40768806) Pleura Pathology biopsy report

0.00

0.0

3.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.96

0.00

2.0

1.8

—

(3011648) Oxygen content in Venous blood

0.00

-0.00

0.0

2.7

—

8.93

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

3.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

-0.00

0.0

1.2

—

(3045788) Cell count panel - Pleural fluid

0.00

-0.00

0.0

2.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.96

-0.00

6.0

8.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

257.86

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.2

—

4.76

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

-0.00

0.0

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

-0.00

0.0

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.2

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

7.4

—

48.67

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

0.00

-0.00

0.0

2.0

—

53.20

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_SWEET_SDR and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_SWEET_SDR.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_SWEET_SDR – Sweet's syndrome

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sweet's syndrome

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints